Renovaro Biosciences Inc. - Common Stock RENB 深 沪
已收盘 09-30 16:00:00 美东时间
1.40
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.40
- 总市值 0
- 52周最高 2.10
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.1214
- 委 比 0.00%
- 总股本 --
- 历史最高 5.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.1214
- 每 手 1
- 风险率 0.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
Renovaro Inc.'s subsidiary, BioSymetrics, receives a patent allowance for "Methods, Systems, and Frameworks for Unbiased Data in Drug Discovery Predictions," enhancing data harmonization and AI capabilities for drug discovery and diagnostics in high-growth biomedical markets.
06-03 13:15
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
Renovaro Inc. has secured a court order to expedite a trial for its lawsuit against Predictive Oncology Inc., seeking enforcement of a merger agreement. Predictive Oncology allegedly breached exclusivity and negotiation terms by issuing securities and attempting to terminate the agreement. The case is pending in Delaware with Renovaro seeking specific performance, injunctive relief, and damages.
05-22 15:05
RenovaroCube To Present Cancer Diagnostics Research At ESMO Congress 2024
(NASDAQ:RENB) RenovaroCube (Cube, the Company), a leading AI-driven innovator using multi-omics technology for cancer profiling, is pleased to announce two scientific presentations at a leading cancer conference – the
2024-09-13 21:02
